Genetic fate of recombinant adeno-associated virus vector genomes in muscle - Wikidata - awgldk - TriplyDB

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

http://www.wikidata.org/entity/Q33186207

about

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Gene therapy: light is finally in the tunnel AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity Neurotrophic factors as a therapeutic target for Parkinson's disease Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines.Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.Silencing and un-silencing of tetracycline-controlled genes in neurons Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors Influence of immune responses in gene/stem cell therapies for muscular dystrophies.Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.Gene therapy: design and prospects for craniofacial regeneration.Molecular analysis of vector genome structures after liver transduction by conventional and self-complementary adeno-associated viral serotype vectors in murine and nonhuman primate models Characterization of adeno-associated virus genomes isolated from human tissues.PCR-based detection of gene transfer vectors: application to gene doping surveillance.Cardiac gene therapy Host cell DNA repair pathways in adeno-associated viral genome processing Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.A comparative analysis of constitutive promoters located in adeno-associated viral vectors.AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.Preclinical Development of New Therapy for Glycogen Storage Diseases.Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances Clinical applications involving CNS gene transfer.Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Airway gene therapy and cystic fibrosis.Rapid transgene expression in multiple precursor cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors.Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.DNA-dependent PK inhibits adeno-associated virus DNA integration.The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo.Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution.Focusing brain therapeutic interventions in space and time for Parkinson's disease.Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.

P2860

Q24655262-12C14288-35DF-4A20-B022-3837899E9636 Q27000091-6AAA0A6C-EDE5-41C9-A2CF-261B564393E0 Q27318266-976E342C-21AD-40C3-A62A-244832478A1E Q28273071-CCED5544-462C-4399-9591-EFE147A2DE00 Q28743855-E43C29CC-DB72-4022-ABB0-8159632ECC29 Q30234577-BD608C59-E418-4593-A7F7-AA507559777D Q30431585-813F30FB-0225-4852-968E-32365A24B72C Q30493159-1281448E-8C87-4620-B332-D5B13A8107BC Q30519561-592F547C-9EDD-4D8C-8F8D-F922C0C8778B Q33288257-4141394D-FD6D-4B6E-8D0B-4A3C92506E30 Q33296224-B24BC3D6-DDAA-4438-BB07-BDCB2EFBAFE3 Q33713243-85A71D12-75A3-4A99-9273-A75C4DDDF619 Q33736192-A5474266-3EA3-42B5-99AE-D866A709FE5C Q33737640-4DB70AF5-313C-4772-92FD-E3820F7715D8 Q34007347-B4C586B7-959A-4DB6-BC4F-393CDE735B5B Q34123269-1C197B83-C390-445E-87C4-242CF8062D04 Q34142848-535363B0-C264-4BD0-8E6D-BE1BF6593BCB Q34361637-DBAFBF9B-8904-4888-B9ED-EBDFB832D751 Q34409721-10A47331-145B-4E0B-9630-DAFC17B3E7F1 Q35139314-BB0C0BD0-5FDC-49EF-AFEF-B9DD3DF8E1A5 Q35186003-D6586F0D-C488-483D-91FD-C1F34B4666BA Q35234995-6E0929A1-C7EC-4264-B215-8EFE2E8745D8 Q35238264-6058A019-63B7-4364-9AB2-6BBB2FBC418A Q35596576-2A8F4837-6521-4B97-A956-1807EA369A26 Q35677604-C25F4B89-3C9D-4C4B-8DDD-A0245D8E1CC9 Q35847178-BB80D66F-3D01-43F9-86C8-71A9CB65455A Q35899850-2D6F2171-AC4B-4571-8428-F59D8CBD8A62 Q35904461-48F2FCB5-CD30-47C3-9F86-9B0DF97452E7 Q36079832-2A34D164-CDB2-478E-8FCB-F1ED0EA5F4F0 Q36114209-B6A51B9D-0239-4A1A-8C56-E2ED268284F6 Q36150495-5F5D1A8A-5874-4B8B-85AA-9D33685AE830 Q36151226-DD0F6A2A-01DE-4D5C-8F91-E6A80227E1E0 Q36370376-216D1164-E90D-4991-8D7B-AD97018FFE10 Q36384464-BED5D41B-E02E-43DC-955D-0410908AD94E Q36492202-1999A05D-B51B-4ECE-BAC5-C21F8D8B3698 Q36604872-6AEB5F30-761B-40F5-B507-5FDE43E9D552 Q36613086-FD00D968-95E2-4B1D-9E87-E16B83BBBA26 Q36614445-9112C524-E72B-44E8-8287-9A855CA7F21C Q36745293-E1055A69-DD6B-4B06-BC97-6B9DADBA18FF Q36845715-BFB39EFF-3EA5-43ED-AC71-FD1C1D50DD65

P2860

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

http://www.wikidata.org/entity/Q33186207

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@ast

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@en

type

label

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@ast

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@en

prefLabel

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@ast

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@en

P1433

Q33186207-0F103F0B-E40B-4DEF-B2D4-9A00B4A553EB

P1476

Q33186207-576FA30C-BD52-43EB-A1A1-F9B5F259939E

P2093

Q33186207-3974D753-CB0A-44CF-B53D-2F38A858AAC6

Q33186207-3D0945D1-7598-4416-AA85-9BCC497734F9

Q33186207-CFFD1294-740B-47E5-B286-4443751BC06E

Q33186207-D449A83C-71C3-4968-9F26-60C8F0AAD2FA

Q33186207-FC3381C5-2D59-438A-8A66-1820C2EFE939

P2860

Q33186207-001EDCD7-86ED-4A36-AD19-A6458E806161

Q33186207-060790A0-6894-428A-9477-56A0A0C10B82

Q33186207-07959580-53D6-4410-B9FD-A0EB91E87A03

Q33186207-0D1FD790-97BF-43EF-A9FA-673CD0C86AA7

Q33186207-0F172C12-814B-4921-964D-8472DFA78777

Q33186207-17E908BA-4BAF-42CC-A4D9-203FD8BFA7C6

Q33186207-22C0F0D7-DF0F-4216-9BB4-37FD760169F1

Q33186207-2C0C1A2B-4403-478E-AB29-FFD9191186D5

Q33186207-2CF579DF-1499-4E64-BDF9-24F9245A2963

Q33186207-2F6192C1-E76A-4F27-B84D-9CC02866A8FB

P304

Q33186207-6CDC90ED-F349-48B0-B198-A3A7E8733203

P31

Q33186207-A48A9644-BEA5-4EC8-A67B-52A7776CDBCC

P356

Q33186207-42341D55-2CC2-4A33-9D55-BA3581435F8F

P433

Q33186207-A1596372-A53A-4256-B3DE-74F82F80483F

P478

Q33186207-9DF37D98-DD06-43F8-B362-7438593A3400

P577

Q33186207-B8BCB7E2-1829-47F7-8FC4-14297BABBBC5

P5875

Q33186207-3B8F18B3-F010-4E9A-94DC-1BFF5F6E7059

P698

Q33186207-27CC9D1D-044F-4186-8B2F-F9552C261965

P921

Q33186207-72F42398-F1C6-492A-88BB-E10B9E70BD64

P932

Q33186207-0AC5C4DC-88F3-4AFF-8995-D3F38B19886E

P356

JVI.77.6.3495-3504.2003

P1433

Journal of Virology

P1476

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

@en

P2093

Bruce C Schnepp

http://www.w3.org/2001/XMLSchema#string

Christina A Pacak

http://www.w3.org/2001/XMLSchema#string

Dori L Klemanski

http://www.w3.org/2001/XMLSchema#string

K Reed Clark

http://www.w3.org/2001/XMLSchema#string

Philip R Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.

Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model

Site-specific integration by adeno-associated virus

Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA

Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors

A colony bank containing synthetic CoI EI hybrid plasmids representative of the entire E. coli genome

Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets.

Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver.

P304

3495-3504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.6.3495-3504.2003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10879973

http://www.w3.org/2001/XMLSchema#string

P698

12610125

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

149530

http://www.w3.org/2001/XMLSchema#string